Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases. With a state-of-the-art facility for biopharmaceutical product development and manufacturing and highly experienced pharmaceutical industry leadership, Scinai offers end-to-end boutique CDMO services in parallel to developing its own pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized VHH antibody (NanoAb) pipeline targeting diseases with large unmet medical needs. Company website: www.scinai.com


Pharmaceutical

Scinai Immunotherapeutics

Scinai Immunotherapeutics' headquarters in Ness Ziona, Israel

Amir Reichman

Elad Mark 

Uri Ben-Or

Tamar Ben-Yedidia

Morris Laster

Samuel Moed

Avner Rotman

Adi Raviv

Mark Germain

Yael Margolin

Jay Green

Leadership Team

Technical and Research Team

Executive

Corporate Administration Team

Scinai Immunotherapeutics

Org chart

Board & advisors

Teams

Leadership Team

Technical and Research Team

Executive

Corporate Administration Team

Offices

Similar companies